Tamara Mills

Baymatob is an Australian company aiming to transform the health outcomes of mothers and their babies, by providing early warning for treatable complications. Baymatob are developing a digital platform, powered via our core-technology, a wearable sensor, Oli. Oli’s ability to monitor complex and novel sets of physiological information is unprecedented in maternal health. It provides the opportunity to create an entirely new standard of care, allowing clinicians to be proactive, aiming to reduce the prevalence and severity of severe complications. Baymatob was founded after the traumatic birth experience the companys Founder, Sarah McDonald, had with her second child. It was this experience that made clear the need to do better in obstetrics monitoring.

Valiant aspires to improve humanity’s access to the Moon, Mars and beyond by enabling sustainable growth through fast, safe and clean propulsion.

Baymatob is an Australian company aiming to transform the health outcomes of mothers and their babies, by providing early warning for treatable complications. Baymatob are developing a digital platform, powered via our core-technology, a wearable sensor, Oli. Oli’s ability to monitor complex and novel sets of physiological information is unprecedented in maternal health. It provides the opportunity to create an entirely new standard of care, allowing clinicians to be proactive, aiming to reduce the prevalence and severity of severe complications. Baymatob was founded after the traumatic birth experience the companys Founder, Sarah McDonald, had with her second child. It was this experience that made clear the need to do better in obstetrics monitoring.

Valiant aspires to improve humanity’s access to the Moon, Mars and beyond by enabling sustainable growth through fast, safe and clean propulsion.

Predict Ltd provides strategic and transactional consultancy to clients seeking to create value in the Nuclear Medicine / Imaging / Radiotherapeutics space. What we believe in: - Value Based Pricing - Dependability & Security of Supply - Customer & Patient Focused - Innovation & Disruption - Building Teams & Growth - 360 Degree Understanding Current & Completed Assignments - Advising a leading Private Equity Company regarding the possible sale of a global Nuclear Medicine Company. - Strategic Advisor to Urenco Limited regarding Medical Isotopes - Strategic Advisor to SHINE Medical - Strategic Advice for Cardinal Health, Nuclear & Precision Health Solutions -Advising the Australian Government, through ANSTO – appointed to develop an independent business case that expertly considers the options available to provide a secure medium to long term sustainable future of nuclear medicine supply to patients in Australia.

We believe the power of creativity is limitless. We exist to accelerate Australias future, where creativity meets technology. Creative Tech Ventures Fund is an Seed to Series A stage venture capital fund that invests in Australia’s most promising creative tech startups. Creative tech is a highly disruptive industry that is at the forefront of cross-cutting business models across fashion, screen, advertising, product design, digital media, multimedia, music, games, computing, robotics, engineering and electronics. We help founders grow market defining ventures. This includes augmented reality (AR), virtual reality (VR), programmatic branding, creative robotics, immersive technologies and the application of interactivity to markets in performance and experience. CTV Fund is currently raising, to be registered as a Venture Capital Limited Partnership. The fund is managed by QUT Creative Enterprise Australia. CEA is a specialist commercialisation, business accelerator and investment company, owned by the Queensland University of Technology. For over a decade, CEA has pioneered innovative services to grow and accelerate creative tech startups. Company profile provided is general information only, it is not an offer to invest in any product. Creative Industries Precinct Pty Ltd t/as QUT Creative Enterprise Australia (CEA) (ACN 009 110 924) is the Manager of Creative Tech Ventures Fund. CEA has been appointed as a corporate authorised representative (No: 1267867) of AFSL No: 401224.

Edale Capital is an Australian based single family office with active interests in various asset classes including listed equities, real assets, private equity, venture capital and special projects. Edale Capital is a long-term investor, with the capacity to invest across multiple generations of funds.